Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
4:55 PM Apr 24, 2018
Shire to consider revised Takeda bid
Shire plc (LSE:SHP; NASDAQ:SHPG) said late Tuesday its board is willing to recommend to shareholders a...
3:47 PM Apr 24, 2018
Amgen considering risk-based Aimovig pricing
On a conference call to discuss 1Q18 earnings call, Amgen Inc. (NASDAQ:AMGN) EVP of Global Commercial...
3:24 PM Apr 24, 2018
Merck adds affinity optimization to nanoscale synthesis system
A Nature paper from Merck & Co. Inc. (NYSE:MRK) describes a nanoscale synthesis system that...
3:15 PM Apr 24, 2018
Diabetes franchise drives 1Q18 for Lilly
Strong sales from the diabetes franchise of Eli Lilly and Co. (NYSE:LLY) led to 1Q18 results that outpaced...
2:22 PM Apr 24, 2018
HKEX finalizes biotech chapter listing rules
Hong Kong Exchanges and Clearing Ltd. (HKEX) released final rules for the listing of pre-revenue biotech...
2:16 PM Apr 24, 2018
Biogen looks to ex-U.S. markets for growth
Biogen Inc. (NASDAQ:BIIB) perceives greater long-term growth opportunities than anticipated in the EU and...
1:13 PM Apr 24, 2018
Imfinzi combo misses in NSCLC subpopulation
AstraZeneca plc (LSE:AZN; NYSE:AZN) said Imfinzi durvalumab plus tremelimumab as third-line treatment...
1:07 PM Apr 24, 2018
Carter introduces 340B transparency bill
Congressman Earl Carter (R-Ga.) introduced legislation Tuesday to increase transparency into the 340B drug...
10:34 AM Apr 24, 2018
Epizyme falls on clinical hold
Epizyme Inc. (NASDAQ:EPZM) fell $2.30 (15%) to $13 in afternoon trading Tuesday after reporting late...
10:05 AM Apr 24, 2018
PureTech names Joep Muijrers CFO
PureTech Health plc (LSE:PRTC) hired Joep Muijrers as CFO. He was a partner and portfolio manager at Life...
8:23 AM Apr 24, 2018
Reed replacing Zerhouni at Sanofi
Head of Global R&D Elias Zerhouni will retire from Sanofi (Euronext:SAN; NYSE:SNY), effective June 30....
8:16 AM Apr 24, 2018
Supreme Court retains, complicates IPR
The Supreme Court Tuesday upheld the constitutionality of the inter partes review process for challenging...
6:59 AM Apr 24, 2018
Nextech leads Revolution Medicines' $56M series B
Revolution Medicines Inc. (Redwood City, Calif.) raised $56 million in a series B round led by new...
4:17 AM Apr 24, 2018
Protein stability play Cedilla launches with $56.2M series A
Third Rock Ventures launched Cedilla Therapeutics Inc. (Cambridge, Mass.) with a tranched $56.2 million...
4:24 PM Apr 23, 2018
FDA committee split on Olumiant dosing
FDA's Arthritis Advisory Committee voted Monday in favor of approving a once-daily 2 mg dose of rheumatoid...
4:07 PM Apr 23, 2018
Management tracks: Probiodrug, Alder
Neurology company Probiodrug AG (Euronext:PBD) said Chairman and CEO Konrad Glund will retire, effective...
4:05 PM Apr 23, 2018
Clarus, Sofinnova Partners announce new hires
Life sciences investment firm Clarus Ventures LLC (Cambridge, Mass.) hired Paris Panayiotopoulos as...
3:53 PM Apr 23, 2018
CAR T against cell surface proteins to treat prostate cancer
Researchers at University of California Los Angeles identified cell surface targets to treat prostate...
3:43 PM Apr 23, 2018
FDA places hold on Epizyme's tazemetostat
Epizyme Inc. (NASDAQ:EPZM) fell $2.90 (19%) to $12.40 in after-hours trading Monday after FDA placed a...
3:33 PM Apr 23, 2018
Ping An Healthcare sets IPO range
Ping An Healthcare and Technology Co. Ltd. (Shanghai, China) amended its IPO on the Hong Kong stock...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.